Henry U. Bryant

Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats

Masahiko Sato, Marian K. Rippy, Henry U. Bryant · The FASEB Journal · 1996 · 287 citations

Medicine, Endocrinology, Pharmacology +16

Molecular determinants of tissue selectivity in estrogen receptor modulators

Timothy A. Grese, James P. Sluka, Henry U. Bryant et al. · Proceedings of the National Academy of Sciences · 1997 · 243 citations

Life Sciences, Endocrinology, Pharmacology +17

Orally Bioavailable GSK-3α/β Dual Inhibitor Increases Markers of Cellular Differentiation In Vitro and Bone Mass In Vivo

Nalini H. Kulkarni, Jude E. Onyia, Qingqiang Zeng et al. · Journal of Bone and Mineral Research · 2006 · 181 citations · Full text

Medicine, Endocrinology, Bone Metabolism +15

Discovery and Synthesis of [6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]- 2-(4-hydroxyphenyl)]benzo[<i>b</i>]thiophene:  A Novel, Highly Potent, Selective Estrogen Receptor Modulator

Alan D. Palkowitz, Andrew L. Glasebrook, K. Jeff Thrasher et al. · Journal of Medicinal Chemistry · 1997 · 177 citations

Pharmacy, Medicinal Chemistry, Pharmacology +7

Structure−Activity Relationships of Selective Estrogen Receptor Modulators:  Modifications to the 2-Arylbenzothiophene Core of Raloxifene

Timothy A. Grese, Stephen Cho, Don R. Finley et al. · Journal of Medicinal Chemistry · 1997 · 176 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12